85766-212-03 : NDC 2026 Code

85766-212-03 : Glucagon ( Baqsimi )

Additionally :

You can get information about “85766-212-03” NDC code in 85766-212-03 in HTML format

HTML | 85766-212-03 in TXT (Plain Text) format

TXT | 85766-212-03 in PDF (Portable Document Format)

PDF | 85766-212-03 in XML format

XML formats.

NDC Code : 85766-212-03 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "85766-212-03",
    "PackageDescription": "1 TUBE in 1 CARTON (85766-212-03)  / 1 BOTTLE, UNIT-DOSE in 1 TUBE / 1 POWDER in 1 BOTTLE, UNIT-DOSE",
    "NDC11Code": "85766-0212-03",
    "ProductNDC": "85766-212",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Baqsimi",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Glucagon",
    "DosageFormName": "POWDER",
    "RouteName": "NASAL",
    "StartMarketingDate": "20190724",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA210134",
    "LabelerName": "Sportpharm LLC",
    "SubstanceName": "GLUCAGON",
    "StrengthNumber": "3",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-06-24",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260619",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}